Register for OXB’s Capital Markets Event: 2 June 2026

News: OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category

EIAV-Based Retinal Gene Therapy in the Shaker1 Mouse Model for Usher Syndrome Type 1B: Development of UshStat

September 17, 2024